Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. [electronic resource]
Producer: 20120411Description: 987-94 p. digitalISSN:- 1532-8422
- Adolescent
- Aging -- physiology
- Anticoagulants -- therapeutic use
- Blood Coagulation Disorders -- diagnosis
- Blood Loss, Surgical
- Blood Transfusion -- statistics & numerical data
- Cardiac Surgical Procedures -- methods
- Cardiopulmonary Bypass -- methods
- Child
- Child, Preschool
- Echocardiography, Transesophageal
- Factor VIIa -- adverse effects
- Female
- Heart Defects, Congenital -- surgery
- Hemostatics
- Heparin Antagonists -- therapeutic use
- Humans
- Infant
- Infant, Newborn
- Male
- Off-Label Use
- Partial Thromboplastin Time
- Postoperative Hemorrhage -- drug therapy
- Protamines -- therapeutic use
- Prothrombin Time
- Recombinant Proteins -- adverse effects
- Retrospective Studies
- Thrombosis -- diagnosis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.